Jan-Paul Simard reports a stock award at XBiotech
By AlphaYouPublished Form 4
Simard Jan-Paul
Reporting filer
Jan-Paul Simard reports a stock award, not an open-market purchase or sale, in XBiotech Inc.. Form 4 filed Oct 28, 2026 lists 1 entry.
- Disclosed
- Oct 28, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (derivative) | Simard Jan-Paul | 2026-10-26 | A | Grant or award | 2000000 | 0 | 2,000,000 | 2 days | Filed terms
|
Stock Option (derivative)
- Owner
- Simard Jan-Paul
- Date
- 2026-10-26
- Code
- A
- Action
- Grant or award
- Quantity
- 2000000
- Price
- 0
- Following holdings
- 2,000,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option
- conversion Or Exercise Price: 1.85
- transaction Date: 2026-10-26
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 2000000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- exercise Date: 2027-04-24
- expiration Date: 2036-10-26
- underlying Security Title: Common Stock
- underlying Security Shares: 2000000
- shares Owned Following Transaction: 2000000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Simard Jan-Paul: Co-Chief Executive Officer.
Original sources
Prepared automatically from public filing data. Report a correction.